Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft‐tissue sarcoma patients in the competing risks setting

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|21|3361-3369

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.21, 2014-11, pp. : 3361-3369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic factors and follow‐up strategy for superficial soft‐tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 8, 2015-06 ,pp. : 951-956

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Relevance of a Histological Grading System Using MIB-1 for Adult Soft-Tissue Sarcoma

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 66-74

Karger

Access to resources Recommend Favorite

Long‐term local disease control in a recurrent soft‐tissue sarcoma of the thigh treated by radiofrequency ablation

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 6, 2015-05 ,pp. : 708-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 333-338

Karger

Access to resources Recommend Favorite

Prognostic Factors of Treatment Outcomes in Patients with Granulocytic Sarcoma

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 238-246

Karger

Access to resources Recommend Favorite